Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

124862 Press Releases
DateTitleCompany
06 Oct 15 Peter Thiel’s Breakout Labs Selects Four New Companies Pushing the Boundaries of Science and Technology Thiel Foundation,
Published by
Business Wire
06 Oct 15 Cardax to Lead Aging Discussion at Chaminade University Cardax, Inc.,
Published by
Business Wire
06 Oct 15 MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy MyoKardia, Inc.,
Published by
Business Wire
06 Oct 15 MD Anderson, Theraclone Sciences form OncoResponse Theraclone Sciences and MD Anderson,
Published by
Business Wire
06 Oct 15 Photometrics® Launches Intelligent Scientific CMOS Camera with Signal Restoration Super Powers Photometrics,
Published by
Business Wire
06 Oct 15 DNAnexus Partners With QIAGEN to Integrate Its Cloud Genomics Platform With Ingenuity Variant Analysis DNAnexus Inc.,
Published by
Business Wire
06 Oct 15 HealthWarehouse.com Awarded 2015 Bizrate® Circle of Excellence Award HealthWarehouse.com, Inc.,
Published by
Business Wire
06 Oct 15 Teva Reinforces Focus on Advancing Multiple Sclerosis Treatment at 31st ECTRIMS Congress Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 15 Ritter Pharmaceuticals Appoints AnnKatrin Petersen-Jappelli, M.D., M.SC. as Chief Medical Officer Ritter Pharmaceuticals, Inc.,
Published by
Business Wire
06 Oct 15 Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds Osiris Therapeutics, Inc.,
Published by
Business Wire
06 Oct 15 Akebia Reaches Agreement with FDA and EMA on Vadadustat Global Phase 3 Program Akebia Therapeutics, Inc.,
Published by
Business Wire
06 Oct 15 Abstract Presentations Address Key Clinical Questions Regarding the Vesair® Bladder Control System for the Treatment for Stress Urinary Incontinence (SUI) Solace Therapeutics, Inc.,
Published by
Business Wire
06 Oct 15 Exact Sciences to Host Webcast and Conference Call Regarding U.S. Preventive Services Task Force Draft Recommendations Exact Sciences Corp.,
Published by
Business Wire
06 Oct 15 Rush-Copley Medical Center Selects Merge Healthcare to Further Enhance Patient Care Published by
GlobeNewswire
06 Oct 15 Akers Biosciences Commercializes New App-Enabled Tests for Health and Wellness Industry and Consumers Published by
GlobeNewswire
06 Oct 15 Adaptimmune Announces New Research and Development Facility in Oxfordshire Published by
GlobeNewswire
06 Oct 15 SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217 Published by
GlobeNewswire
06 Oct 15 BioNano Genomics Data Demonstrate Next-Generation Mapping as New Standard for Accurate and Complete Genome Assembly Published by
GlobeNewswire
06 Oct 15 St. Louis-based 2e Creative named 2015 Small Healthcare Agency of the Year by Medical Marketing & Media 2e Creative, Inc.,
Published by
PR Newswire
06 Oct 15 Make-A-Wish® Ohio, Kentucky & Indiana Grants Record 916 Wishes in 2015 for Area Kids Make-A-Wish Ohio, Kentucky and Indiana,
Published by
PR Newswire
06 Oct 15 New-To-Mass-Market DayClear Allergy & Sinus Medicines Present Uncommon Formula GM Pharmaceuticals,
Published by
PR Newswire
06 Oct 15 U.S. Health Coalition Releases Medicine Safety Tips for 2015 Cold and Flu Season Acetaminophen Awareness Coalition,
Published by
PR Newswire
06 Oct 15 Infinity to Provide Update on Duvelisib and Immuno-Oncology Development Candidate IPI-549 During 2015 Research and Development Day Infinity Pharmaceuticals, Inc.,
Published by
PR Newswire
06 Oct 15 Axovant Sciences Announces Start Of Confirmatory Phase 3 MINDSET Study And Special Protocol Assessment (SPA) Agreement With FDA Axovant Sciences Ltd.,
Published by
PR Newswire
06 Oct 15 Envisia Therapeutics' Lead Product Candidate, ENV515 (travoprost XR), Achieves Primary Efficacy Endpoint In Phase 2a Glaucoma Clinical Trial Envisia Therapeutics,
Published by
PR Newswire
06 Oct 15 Complete Genomics Announces UK Epilepsy Society's Acquisition of Its Revolocity™ Supersequencer Complete Genomics, Inc.,
Published by
PR Newswire
06 Oct 15 AcelRx Pharmaceuticals Announces Initiation of Clinical Study with ARX-04 in Emergency Room Patients with Moderate-to-Severe Acute Pain AcelRx Pharmaceuticals, Inc.,
Published by
PR Newswire
06 Oct 15 Global Human Albumin Market: Extra Revenues to Come through Non-Therapeutic Applications Frost & Sullivan,
Published by
PR Newswire
06 Oct 15 Adaptimmune Announces New Research and Development Facility in Oxfordshire Adaptimmune Therapeutics plc,
Published by
GlobeNewswire
06 Oct 15 Nexvet to Host Animal Health Symposium in New York City Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.